British Journal of Haematology,2014,166,496-513
Glucagon is responsible for increasing blood sugar levels in your body
For obesity treatment, dose escalation protocols starting at lower doses (e.g., 2 mg) and gradually increasing to maintenance doses (e.g., 4 mg, 8 mg, or 12 mg) have been studied Link below for more detailed information: Product Overview: Retatru/Cagrilintide is a dual-compound research peptide combining Retatru, a novel multi-agonist peptide with activity across GLP-1, GIP, and glucagon pathways, and Cagrilintide, an amylin analog
HUBERMAN: Melanocyte-stimulating hormone has the effect of stimulating pigmentation of the skin by activating what are called melanocytes that exist within the skin
Santra M, Zhang ZG, Yang J, Santra S, Santra S, Chopp M, Morris DC